Expansion Opportunities Vaxxinova is actively expanding its regional footprint with new hires and leadership in key markets (Poland poultry account manager, Indonesia country representative) and has recently grown its Latin American presence by acquiring Labovet in Brazil, signaling readiness for channel and distribution expansion in emerging markets.

Strategic Acquisitions The Labovet acquisition in Brazil strengthens market access and product portfolio in Latin America, presenting cross-selling and integration opportunities for diagnostics and vaccines across poultry, livestock, and aquaculture segments.

Poultry Focus Several recent activities center on poultry: attendance at VIV Europe and Poultry Days, and a dedicated poultry key account hire in Poland, indicating a strong sales funnel for poultry vaccines and diagnostic services in Europe and export markets.

R&D Driven Heavy emphasis on R&D and innovation positions Vaxxinova to offer premium, research-backed solutions; leverage for upsell of advanced diagnostics, tiered vaccine portfolios, and tailored livestock-health programs to premium customers seeking cutting-edge products.

Global Reach, Local Ops Multi-country production, R&D, and sales footprint across 12 countries with active presence in over 75 markets creates opportunities for multi-country contracts, regional service packages, and scalable supply agreements for multinational livestock operations.